Co-development of a new medicinal product
Reference number | |
Coordinator | ZuLa Diagnostics AB |
Funding from Vinnova | SEK 25 000 |
Project duration | September 2018 - December 2018 |
Status | Completed |
Important results from the project
We have had several B2B meetings in Beijing, Nanjing and Shanghai. This has given us some good contacts for further discussions and potential collaboration.
Expected long term effects
We are looking forward to have visitors from Nanjing coming to Stockholm to continue discussions before the end of the year.
Approach and implementation
Keep the discussions going on-line and prepare for the visit to Stockholm.